Almokalant is a class III antiarrhythmic drug, acts as apotassium channelblocker, and inhibits a specific component (Ikr) of the time-dependent delayed rectifier K⁺current.

Potassium channel^[1]

Almokalant is a class III antiarrhythmic drug, acts as a potassium channel blocker, and inhibits a specific component (Ikr) of the time-dependent delayed rectifier K⁺current^[1].

Almokalant (125 μmol/kg, p.o.) induces cardiovascular defects, orofacial clefts, and tail defects in pregnant rats, after administration on Day 11. Almokalant also causes in pregnant rats^[1].

352.49

C₁₈H₂₈N₂O₃S

123955-10-2

阿莫兰特

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.